Risk of medication error administering ciprofloxacin oral suspension in children
Eur J Clin Pharmacol
.
2015 Jun;71(6):769-770.
doi: 10.1007/s00228-015-1842-y.
Epub 2015 Apr 15.
Authors
Audrey Lajoinie
1
2
,
Frederic V Valla
3
,
Behrouz Kassai
4
5
;
EREMI Group
Affiliations
1
EPICIME-CIC 1407 Inserm, Service de Pharmacologie Clinique, Hospices Civils de Lyon, F-69677, Bron, France.
[email protected]
.
2
UMR 5558 CNRS, Laboratoire de Biométrie et Biologie Evolutive, Université Claude Bernard/Lyon1, F-69622, Villeurbanne, France.
[email protected]
.
3
Service de Réanimation Pédiatrique, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, F-69677, Bron, France.
4
EPICIME-CIC 1407 Inserm, Service de Pharmacologie Clinique, Hospices Civils de Lyon, F-69677, Bron, France.
5
UMR 5558 CNRS, Laboratoire de Biométrie et Biologie Evolutive, Université Claude Bernard/Lyon1, F-69622, Villeurbanne, France.
PMID:
25877020
DOI:
10.1007/s00228-015-1842-y
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Administration, Oral
Ciprofloxacin / administration & dosage*
Drug Packaging
Humans
Infant
Infant, Newborn
Medication Errors / adverse effects*
Risk
Suspensions / therapeutic use
Substances
Suspensions
Ciprofloxacin